TherapeuticsMD stock forecast, TXMD price prediction

TherapeuticsMD (TXMD) Stock Price Forecast

12-month forecast. Price targets made by 4 analysts.

Minimum Forecast

$4

Average Forecast

$4.75

TherapeuticsMD Inc stock returns on equity (ROE) forecast

Will TherapeuticsMD Inc be a profitable investment for shareholders?
TXMD

20.12%

Industry

72.47%

Market

13.52%

TherapeuticsMD Inc stock return on assets (ROA) forecast

how much profit will TherapeuticsMD Inc be able to generate from its assets?
TXMD

-$0.41-16.33%

Industry

-$0.20-59.18%

Market

#VALUE!

stock-forecast-recommendations

A new way to identify winning stocks

Our tool analyzes more than 3.000 stocks monthly, ranking them based on traffic growth, user acquisition, hiring trends, analyst ratings, and more.

badge
Consistently beating the S&P500,
Nasdaq and Dow Jones.
Analyst recomendation

Buy

Investment opportunity: good
Strong Buy: 4

100%

Buy: 0

0%

Hold: 0

0%

Strong Sell: 0

0%

Sell: 0

0

TXMD stock earnings per share (EPS)

How much of new income will be owned by each shareholder within the next years?
Avg 1 year forecast: $99.4M (+17.29%)
Avg 2 year forecast: $203.0M (+139.39%)
Avg 3 year forecast: $260.3M (+206.98%)

TXMD stock revenue forecast

How much money is TherapeuticsMD Inc likely to bring in the coming years?
Avg 1 year forecast: 46.75%)
Avg 2 year forecast: 25.35%)
Avg 3 year forecast: 12.16%)

TherapeuticsMD Inc stock earnings-growth forecast

How much do analyst expect TXMD to grow during the next years?
TXMD

Industry

Market

TherapeuticsMD Inc stock revenue-growth forecast

How much do analyst expect TherapeuticsMD Inc's revenue to grow during the next years?
TXMD

Industry

Market

What is the stock price forecast of TherapeuticsMD for the next 12 months?
The average TherapeuticsMD stock forecast price is $4.75, with $4 representing the minimum price forecast and $5 the highest. According to the forecast made by 4 analysts, TherapeuticsMD Inc stock is a good investment opportunity with a potential upside of 579% in the next 12 months.
According to analysts’ forecasts, is TXMD stock expected to go up?
Analysts believe that in the short term, TherapeuticsMD stock is to Buy. Out of 4 analysts, 4 (100%) think that TXMD is a strong buy, 0 (0%) think that TXMD is a buy, 0 (0%) think that TXMD is a hold, 0 (0) think that TXMD is a sell, 0 (0%) think that TXMD is a strong sell. As per the middle term, analysts expect TherapeuticsMD stock to upside, reaching a maximum forecasted price of $5.
How much can I expect to make investing in TXMD in 12 months?
Analysts predict the price of TXMD to reach $4.75 next year. If correct, $7000 invested on Oct 7th, 2021 would result in a profit of $41188. To give a perspective, shares of 7000 bought on Dec 21st, 2020 would have returned on Oct 7th, 2021 $-3073, hence a -43.9% return on investment.
What is TherapeuticsMD's ROE, ROA, and EPS forecast?
Analysts forecast TherapeuticsMD's ROE to increase by 20.12% in the next three years. They expect the industry to grow by 72.47% and the US market to grow by 13.52% during the same period. TherapeuticsMD's ROA instead is likely to increase by -$0.41-16.33% versus a -$0.20-59.18% forecast industry growth. Similarly, TherapeuticsMD''s EPS is expected to reach $99.4M (+17.29%) in one year, $203.0M (+139.39%) in two years, and $260.3M (+206.98%) in three years.